What is King Pharmaceuticals's workers' compensation — year 3?

King Pharmaceuticals (KG) reported workers' compensation — year 3 of 18.3% in Q4 2025.

What does workers' compensation — year 3 mean?

This metric captures the financial performance or claim activity for the third year of the workers' compensation policy cycle. It serves as a key indicator of how claims stabilize as they move further from the initial policy inception date. This data point is essential for evaluating the long-term profitability and reserve adequacy of the workers' compensation segment.

King Pharmaceuticals KG Workers' Compensation — Year 3

Other product segments

Commercial Auto Liability

18.7%—

General Liability

13.1%—

European Hospital Liability

10.4%—

All other lines

2.7%—

International

2.7%—

Similar metrics at other companies

ORIWorkers' Compensation — Year 3

13.6%-0.8pp

CNAWorkers' Compensation — Year 3

14.5%+0.3pp

HIGWorkers' Compensation — 3rd Year

12.2%+0.1pp

PRA

PRAWorkers' Compensation Insurance — Historical claims duration, year 3 (percent)

14.4%-0.2pp

SIGIWorkers Compensation — Short-duration insurance contracts, historical claims duration, year three

14.1%+1.0pp

UFCSCommercial workers' compensation — Year 3

13.8%-0.7pp

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's workers' compensation — year 3.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's workers' compensation — year 3?: King Pharmaceuticals (KG) reported workers' compensation — year 3 of 18.3% in Q4 2025.
What does workers' compensation — year 3 mean?: This metric captures the financial performance or claim activity for the third year of the workers' compensation policy cycle. It serves as a key indicator of how claims stabilize as they move further from the initial policy inception date. This data point is essential for evaluating the long-term profitability and reserve adequacy of the workers' compensation segment.